Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NEK2 | P51955 | 3/20 | 0.63 |
| ▸ | CAMKK2 | Q96RR4 | 2/20 | 0.55 |
| ▸ | MAP2K1 | Q02750 | 1/20 | 0.53 |
| ▸ | PRKCI | P41743 | 1/20 | 0.53 |
| ▸ | CDC7 | O00311 | 3/20 | 0.47 |
| ▸ | KDR | P35968 | 2/20 | 0.47 |
| ▸ | PIM1 | P11309 | 2/20 | 0.47 |
| ▸ | PLK4 | O00444 | 1/20 | 0.47 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.47 |
| ▸ | AURKA | O14965 | 1/20 | 0.47 |
| ▸ | MAPK13 | O15264 | 1/20 | 0.47 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.47 |
| ▸ | DYRK3 | O43781 | 1/20 | 0.47 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.47 |
| ▸ | RPS6KA5 | O75582 | 1/20 | 0.47 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.47 |
| ▸ | PAK4 | O96013 | 1/20 | 0.47 |
| ▸ | CHEK2 | O96017 | 1/20 | 0.47 |
| ▸ | ABL1 | P00519 | 1/20 | 0.47 |
| ▸ | EGFR | P00533 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL856986 | 0.87 | NEK2 (0.60) | NEK2CAMKK2MAP2K1PRKCICDC7 | |
| SCHEMBL857000 | 0.85 | NEK2 (0.58) | NEK2CAMKK2MAP2K1CDC7KDR | |
| SCHEMBL15282974 | 0.85 | NEK2 (0.59) | NEK2CAMKK2MAP2K1PRKCIKDR | |
| SCHEMBL858554 | 0.84 | NEK2 (0.57) | NEK2CAMKK2MAP2K1CDC7KDR | |
| SCHEMBL878800 | 0.84 | NEK2 (0.57) | NEK2CAMKK2MAP2K1CDC7KDR | |
| SCHEMBL878719 | 0.83 | MAP2K1 (0.61) | NEK2CAMKK2MAP2K1KDRCDK2 | |
| SCHEMBL3699180 | 0.83 | DYRK1A (0.58) | NEK2PRKCICDC7KDRPIM1 | |
| SCHEMBL3711232 | 0.83 | CAMKK2 (0.54) | NEK2CAMKK2MAP2K1PRKCICDC7 | |
| SCHEMBL12675734 | 0.82 | NEK2 (0.76) | NEK2CAMKK2MAP2K1PRKCICDC7 | |
| SCHEMBL1907324 | 0.82 | NEK2 (0.67) | NEK2CAMKK2MAP2K1CDC7KDR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120122860-A1 | SOLID FORMS OF SULFONAMIDES AND AMINO ACIDS | PLEXXIKON, INC. | 2012-05-17 | — | — | US | disclosed |
| WO-2010129570-A1 | SOLID FORMS OF SULFONAMIDES AND AMINO ACIDS | PLEXXIKON, INC. (US) | 2010-11-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120122860-A1 | SOLID FORMS OF SULFONAMIDES AND AMINO ACIDS | BRAF, RAF1, ARAF | NEK2 949/4885CAMKK2 497/4885MAP2K1 131/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.